-
Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.
Arterioscler Thromb Vasc BiolSeidelmann SB, Kuo C, Pleskac N, Molina J, Sayers S, Li R, Zhou J, Johnson P, Braun K, Chan C, Teupser D, Breslow JL, Wight TN, Tall AR, Welch CL -
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses.
Journal of ImmunologyZhou B, Headley MB, Aye T, Tocker J, Comeau MR, Ziegler SF -
Functional analysis of FOXP3.
Annals of the New York Academy of SciencesBuckner JH, Ziegler SF -
Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor.
Journal of ImmunologyLee HC, Headley MB, Iseki M, Ikuta K, Ziegler SF -
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity.
DiabetologiaMartin-Pagola A, Sisino G, Allende G, Dominguez-Bendala J, Gianani R, Reijonen H, Nepom GT, Ricordi C, Ruiz P, Sageshima J, Ciancio G, Burke GW, Pugliese A -
Approaching the Heisenberg principle of immunology.
Clinical ImmunologyNepom GT -
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Diabetes CareGreenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research Group., European C-Peptide Trial Study Group. -
The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.
Infect ImmunKwok WW, Yang J, James EA, Bui J, Huston L, Wiesen AR, Roti M -
Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response.
J ImmunolJessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BR, Ziegler SF, Comeau MR -
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.
PNAS USAHe R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS -
Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.
Human ImmunologyKlucar P, Barnes PF, Kong Y, Samten B, Tvinnereim A, Spallek R, Nepom GT, Singh M, Shams H -
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
Journal of AutoimmunityYang J, Danke N, Roti M, Huston L, Greenbaum CJ, Pihoker C, James EA, Kwok WW -
Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.
The Mount Sinai Journal of Medicine, New YorkBollyky J, Sanda S, Greenbaum CJ -
Regulatory T cells and inflammation: better late than never.
ImmunityZiegler SF
